Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Study of the Effects of Epinephrine on Cerebral Oxygenation and Metabolism During Cardiac Arrest and Resuscitation by Hyperspectral Near-Infrared Spectroscopy

Nosrati, Reyhaneh MSc1,2; Lin, Steve MDCM, MSc, FRCPC1,3,4,5; Mohindra, Rohit MDCM, FRCPC6,7; Ramadeen, Andrew MD, PhD3; Toronov, Vladislav PhD1; Dorian, Paul MDCM, MSc, FRCPC3,4

doi: 10.1097/CCM.0000000000003640
Online Laboratory Investigations
Buy
SDC

Objectives: Epinephrine is routinely administered to sudden cardiac arrest patients during resuscitation, but the neurologic effects on patients treated with epinephrine are not well understood. This study aims to assess the cerebral oxygenation and metabolism during ventricular fibrillation cardiac arrest, cardiopulmonary resuscitation, and epinephrine administration.

Design: To investigate the effects of equal dosages of IV epinephrine administrated following sudden cardiac arrest as a continuous infusion or successive boluses during cardiopulmonary resuscitation, we monitored cerebral oxygenation and metabolism using hyperspectral near-infrared spectroscopy.

Settings: A randomized laboratory animal study.

Subjects: Nine healthy pigs.

Interventions: None.

Measurements and Main Results: Our study showed that although continuous epinephrine administration had no significant impact on overall cerebral hemodynamics, epinephrine boluses transiently improved cerebral oxygenation (oxygenated hemoglobin) and metabolism (cytochrome c oxidase) by 15% ± 6.7% and 49% ± 18%, respectively (p < 0.05) compared with the baseline (untreated) ventricular fibrillation. Our results suggest that the effects of epinephrine diminish with successive boluses as the impact of the third bolus on brain oxygen metabolism was 24.6% ± 3.8% less than that of the first two boluses.

Conclusions: Epinephrine administration by bolus resulted in transient improvements in cerebral oxygenation and metabolism, whereas continuous epinephrine infusion did not, compared with placebo. Future studies are needed to evaluate and optimize the use of epinephrine in cardiac arrest resuscitation, particularly the dose, timing, and mode of administration.

1Department of Physics, Ryerson University, Toronto, ON, Canada.

2Physical Sciences Platform, Sunnybrook Research Institute, Toronto, ON, Canada.

3Keenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael’s Hospital, Toronto, ON, Canada.

4Department of Medicine, University of Toronto, Toronto, ON, Canada.

5Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.

6Jewish General Hospital Department of Emergency Medicine, 3755 Ch de la Côte-Sainte-Catherine, Montreal, QC, Canada.

7Department of Critical Care Research, McGill University, Montreal, QC, Canada.

Drs. Nosrati and Lin contributed equally.

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s website (http://journals.lww.com/ccmjournal).

Supported, in part, by the St. Michael’s Foundation Translational Innovation Fund.

Dr. Nosrati is funded by the Natural Sciences and Engineering Research Council of Canada (NSERC) Canada Graduate Scholarship-Doctoral grant. Dr. Lin is Network Investigator of the Cardiac Arrhythmia Network of Canada (CANet) and is supported by a Heart and Stroke Foundation of Canada Ontario Clinician-Scientist award. Dr. Toronov’s institution received funding from NSERC, and he received support for article research from NSERC. Dr. Dorian is Network Investigator of the CANet. The remaining authors have disclosed that they do not have any potential conflicts of interest.

For information regarding this article, E-mail: Reyhane.Nosrati@gmail.com

Copyright © 2018 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.